Ono Pharmaceutical Co. (OTCMKTS:OPHLF - Get Free Report)'s stock price gapped down prior to trading on Wednesday . The stock had previously closed at $10.71, but opened at $9.33. Ono Pharmaceutical shares last traded at $9.33, with a volume of 108 shares changing hands.
Ono Pharmaceutical Stock Down 12.9%
The business's 50 day moving average is $11.09 and its 200-day moving average is $10.62. The company has a debt-to-equity ratio of 0.13, a quick ratio of 2.56 and a current ratio of 3.07. The firm has a market capitalization of $4.38 billion, a price-to-earnings ratio of 13.33 and a beta of 0.52.
Ono Pharmaceutical Company Profile
(
Get Free Report)
Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.
Featured Articles
Before you consider Ono Pharmaceutical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ono Pharmaceutical wasn't on the list.
While Ono Pharmaceutical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
